CONTENTS OF SOME OSTEOTROPIC GROWTH FACTORS AND OSTEOGENESIS MARKERS IN BLOOD OF PATIENTS WITH OSTEOGENESIS IMPERFECTA AND HYPOPHOSPHATEMIC RICKETS

Author: Vykhovanets E.P.¹, Luneva S.N.², Nakoskina N.V.³, Mingazov E.R.⁴, Popkov A.V.⁵

Abstract

In recent years there is intensive growth of the number of genetic diseases such as imperfect osteogenesis and hypophosphatemic rickets. Treatment of this category of patients includes surgical intervention, however in many cases there are recurrences of the disease and the patients have to undergo multiple surgeries. It is known that study of concentration of growth factors and regulatory polyproteins can help in understanding of pathogenetic course of genetic diseases. Material and methods. We studied growth factors and their receptors, bone markers and vitamin D by enzyme-linked immunoassay in blood serum of patients with hypophosphatemic rickets and osteogenesis imperfecta during surgical treatment. The analysis was carried out according to technique from manual to sets eBioscience (TGF-β1, TGF-β2, VEGF-A, VEGF-R2, VEGF-R3), Immunodiagnostic systems (IGF-1, osteocalcin, vitamin D, β-CrossLaps), Invitrogen (VEGF), RayBiotech Inc. (FGF-1, FGF-2, TGF-α, SCF, SCFsR), Mediagnost (IGF-2), QULDEL (pyridinoline), Enzo (DKK-1). Results. It has been established that concentration of growth factors IGF-1, VEGF, FGF-2, TGF-β1, TGF-β2 and their receptors VEGF-R3, SCFsR, bone markers osteocalcin, pyridinoline, as well as vitamin D in blood of patients of different groups at different stages of treatment varied. However, concentration of IGF-1, VEGF-R2 before surgery and ТGF-α on the 60^th day, SCF on the 60^th day in patients with hypophosphatemic rickets and osteogenesis imperfecta did not differ.

Key words

blood serum, growth factors and their receptors, osteogenesis imperfecta, hypophosphatemic rickets, osteosynthesis with the Ilizarov fixator

References

Bochkova N.P. Medical genetics. Moscow: Masterstvo, 2002. 43-45. [In Russian].

Vorob'eva I.S., Nikitina V.V., Gladilin G.P., Shakhmartova S.G., Puchin'yan D.M. The growth factor of vascular endothelium as a predictor of thrombotic complications in patients with deforming coxarthrosis. Tromboz, gemostaz i reologiya = Thrombosis, hemostasis and rheology. 2017. 69 (1). 50-54. [In Russian].

Glants S. Biostatistics. Moscow: Praktika, 1998. 459 p. [In Russian].

Zakharova N., Voskresenskaya O., Tarasova Yu. Angiogenesis and factor of body height of an endothelium of vessels at cerebrovascular pathology. Vrach = Doctor. 2014. (10). 12-14. [In Russian].

Ivanov V.I. Genetics. Textbook for higher education institutions. Moscow: Akademkniga, 2006. 19-27. [In Russian].

Kozlova S.I. Hereditary syndromes and medical genetic counseling. Moscow: Meditsina, 1996. 416 p. [In Russian].

Leviashvili Zh.G., Savenkova N.D., Musaeva A.V., Belov D.Yu. Indices of inorganic phosphate, parathyroid hormone and renal tubular reabsorption of phosphates in children with hereditary hypophosphatemic rickets. Nefgologiya = Nephrology. 2014. 18. (3). 45-56. [In Russian].

Marycheva N.M., Nadyrshina D.D., Khusainova R.I., Zhuchenko N.A., Asanov A.Yu. Osteogenesis imperfecta: intrafamily clinical polymorphism of ethologically uniform disease. Pediatriya = Pediatrics. 2014. 93. (6). 198-199. [In Russian].

Menzorova N.V., Kuznetsova N.L., Smagina M.V. Analysis of disability in the structure of diseases of musculoskeletal system and the consequences of injuries in children of the Sverdlovsk region. Vestnik travmatologii i ortopedii = Reporter of Traumatology and Orthopedics. 2010. 2. (2). 39-41. [In Russian].

Morozov Yu.A. Markers of metabolism of a bone tissue. Spravochnik zaveduyushchego kliniko-diagnosticheskoy laboratoriyey = Handbook of the head of clinical diagnostic laboratory. 2014. (1). 25–33. [In Russian].

Novikov P.V. Rickets and heritable rickets-like diseases in children. Moscow, 2006. 336 p. [In Russian].

Pobel E.A., Bengus L.M., Dedukh N.V. Markers of bone metabolism in remodeling of long bone fractures. Osteoporoz i osteopatii = Osteoporosis and Bone Diseases. 2012. (2). 25–32. [In Russian].

Sergeev V.S., Tikhonenko T.I., Buklaev D.S., Baindurashvili A.G., Afanas'yev B.V. Cell-like therapy of an imperfect bone formation. Geny i kletki = Genes and cells. 2016. 11. (4). 22-23. [In Russian].

Sertakova A.V., Norkin I.A., Rubashkin S.A. Biomarkers of remodeling of a bone tissue and growth factors of body height in diagnostics of stages of an osteonektor of a head of a femur at children. Molekulyarnaya meditsina = Molecular medicine. 2014. (6). 25-29. [In Russian].

Stogov M.V., Luneva S.N., Tkachuk E.A. Biochemical parameters in the prediction of the course of osteoreparative processes in skeletal injury. Klinicheskaya laboratornaya diagnostika = Clinical laboratory diagnostics. 2010. (12). 5-7. [In Russian].

Ul'yanina E.V., Fatkullin I.F., Khayrullina G.R. Angiogenesis and ultrasound markers in assessing the severity of fetal growth retardation syndrome. Vestnik sovremennoy klinicheskoy meditsiny = Bulletin of contemporary clinical medicine. 2016. (5). 79-82. [In Russian].

Shurygin M.G., Shurygina I.A., Dremina N.N. Dynamics of vascular endothelial growth factors and fibroblastic growth factor in experimental myocardial infarction. Byulleten' Vostochno-Sibirskogo nauchnogo tsentra Sibirskogo otdeleniya Rossiyskoy akademii meditsinskikh nauk = Bulletin of East Siberian scientific center of Siberian Branch of Russian Academy of Medical Sciences. 2007. (6). 169–174. [In Russian].

Shchukin A.A., Aranovich A.M., Popkov A.V., Popkov D.A. Assessment of results of lengthening of the lower extremities at patients with the general diseases of a skeleton which are followed by patholologically low body height. Geniy ortopedii = Genius of orthopaedics. 2014. (2). 44-51. [In Russian].

Yakovleva N.Yu., Khazova E.L., Vasil'eva E.Yu., Zazerskaya I.E. Ratio of angiogenic and anti-angiogenic factors in preeclampsia. Arterial'naya gipertenziya = Arterial Hypertension. 2016. 22 (5). 488-494. [In Russian].

Gelinas D.S., Bernatchez P.N., Rollin S., Bazan N.G., Sirois M.G. Immediate and delayed VEGF-mediated NO synthesis in endothelial cells: role of PI3K, PKC and PLC pathways. Br. J. Pharmacol. 2002. 137. (7). 1021-1030.

Haigh J.J., Gerber H.P., Ferrara N., Wagner E.F. Conditional inactivation of VEGF-A in areas of collagen2a1 expression results in embryonic lethality in the heterozygous state. Development. 2000. 127. (7). 1445-53.

Kubisz P., Chud P., Stasko J., Galajda P., Holly P., Vysehradsky R., Mokan M. Circulating vascular endothelial growth factor in the normo-and/or microalbuminuric patients with type 2 diabetes mellitus. Actа Diabetol. 2010. 47. (2). 119-124.

Shimer A.L., Oner F.C., Vaccaro A.R. Spinal reconstruction and bone morphogenetic proteins: open questions. Injury. 2009. 40. (3). 32-38.

Stogov M.V., Luneva S.N., Novikov K.I. Growth factors in human serum during operative tibial lengthening with the Ilizarov method. J. Orthop. Res. 2013. 31. (12). 1966-1970.

Vecchiarelli-Federico L.M., Cervi D., Haeri M., Li-Y A,. Nagy Y. Vascular endothelial growth factor – a positive and negative regulator of tumor growth. Cancer Res. 2010. 70. (3). 863-867.

Volkov M.V. Bone diseases in children. Moscow: Meditsina, 1974. 46s. [In Russian].

Witsch E., Sela M., Yarden Y. Roles for growth factors in cancer progression. Physiology (Bethesda). 2010. 25. (2). 85-101.

About Authors (Correspondence):

Vykhovanets E.P. – postgraduate student, e-mail: vykhovanets.eva@mail.ru

Full Text

snmzh_3-2018_vyhovanec_i_dr.pdf

Received: 28/06/2018

Accepted: 28/06/2018